INVO Bioscience - רווח נקי למניה אחת בשנים עשר החודשים האחרונים INVO

INVO Bioscience, Inc. (INVO) generates revenue from the sale of natural conception capsules, offering an affordable alternative to IVF. The business relies on the unique INVOcell incubation system and biomechanics developments. The company is currently diversifying its structure through a merger with a clinic network. This annual EPS TTM chart demonstrates trend inertia, where the metric value stands at 0.00, helping to filter out market noise.

The scaling of the INVO Bioscience (INVO) reproductive medicine center network is reflected in the current EPS YoY TTM growth rate. This indicator measures the trailing twelve-month earnings per share dynamics to assess the actual increase in business value. The calculation allows for a comparison of market quotes with the actual efficiency of the new vertically integrated business model. It is critical for investors to monitor this pace as a signal of asset liquidity; however, an extreme acceleration of this metric often foreshadows a market correction.